Given a CBC with RBC count 6.14 million/µL, hemoglobin 11.6 g/dL, hematocrit 41.4 %, MCV 67.4 fL, MCH 18.9 pg, MCHC 28.0 g/dL, and RDW 15.8 %, what is the most likely cause of anemia and what diagnostic and treatment steps are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Microcytic Hypochromic Anemia with Elevated RBC Count: Iron Deficiency Anemia

This CBC pattern—microcytic (MCV 67.4 fL), hypochromic (MCH 18.9 pg, MCHC 28.0 g/dL) anemia with an elevated RBC count (6.14 million/µL) and elevated RDW (15.8%)—is most consistent with iron deficiency anemia, and you should immediately order serum ferritin, iron studies (serum iron, TIBC, transferrin saturation), and a peripheral blood smear to confirm the diagnosis.

Understanding the CBC Pattern

The combination of findings here is highly characteristic:

  • Microcytosis (MCV 67.4 fL): Severe microcytosis below 80 fL most commonly indicates iron deficiency, though thalassemia and anemia of chronic disease are differential considerations 1
  • Hypochromia: Both MCH (18.9 pg) and MCHC (28.0 g/dL) are markedly reduced, indicating insufficient hemoglobin in red cells—a hallmark of iron deficiency 2
  • Elevated RBC count (6.14 million/µL): This paradoxical finding occurs because the bone marrow compensates for low hemoglobin by producing more red cells, though each cell is smaller and paler 3
  • Elevated RDW (15.8%): Increased red cell size variability reflects the mixed population of older normal-sized cells and newer microcytic cells, strongly supporting iron deficiency over thalassemia trait (which typically has normal RDW) 4, 5

Diagnostic Algorithm

Immediate Next Steps

  1. Serum ferritin (most powerful test for iron deficiency):

    • <15 µg/L: Diagnostic of iron deficiency 6
    • <30 µg/L: Indicates low iron stores 2
    • <45 µg/L: Consider iron deficiency, especially with inflammation 2
    • 100 µg/L: Iron deficiency almost certainly not present 6

  2. Iron studies:

    • Transferrin saturation <15% confirms absolute iron deficiency 1
    • Low serum iron with elevated TIBC supports diagnosis 1
  3. Peripheral blood smear: Essential to confirm microcytosis, hypochromia, and rule out other causes 1

Distinguishing Iron Deficiency from Thalassemia Trait

The elevated RBC count raises the possibility of thalassemia trait, but several features favor iron deficiency:

  • Elevated RDW: Thalassemia trait typically has normal or only slightly elevated RDW, while iron deficiency shows marked elevation 4, 5
  • Severity of microcytosis: While both cause microcytosis, the pattern differs
  • If ferritin is low: This confirms iron deficiency 6
  • If ferritin is normal with appropriate ethnic background: Order hemoglobin electrophoresis to exclude thalassemia 2, 6

Investigation for Underlying Cause

Once iron deficiency is confirmed, investigate the source of blood loss or malabsorption:

History Focus

  • Gastrointestinal symptoms: Any abdominal pain, change in bowel habits, blood in stool 6
  • Menstrual history: If premenopausal woman, quantify menstrual blood loss 6
  • Medications: NSAIDs, aspirin, anticoagulants 6
  • Dietary intake: Assess iron-rich food consumption, vegetarian/vegan diet 6
  • Family history: Bleeding disorders, GI malignancy, celiac disease 6

Gastrointestinal Investigation

For adults (especially >45 years or with concerning symptoms):

  1. Upper endoscopy with small bowel biopsies:

    • Identifies gastric cancer, peptic ulcer disease, angiodysplasia
    • Small bowel biopsies detect celiac disease (present in 2-3% of IDA cases) 6
    • Expected to reveal cause in 30-50% of patients 6
  2. Colonoscopy or barium enema:

    • Essential even if upper endoscopy finds a lesion (dual pathology occurs in ~10% of cases) 6
    • Excludes colorectal cancer, polyps, inflammatory bowel disease 6
  3. Anti-endomysial antibody testing: If endoscopy not immediately available or patient <45 years without alarm symptoms 6

Common pitfall: Do not assume dietary deficiency or menstruation is the sole cause without excluding GI pathology, as asymptomatic malignancies frequently present with IDA 6

Treatment Approach

Iron Supplementation

Start immediately while investigating underlying cause:

  • Ferrous sulfate 200 mg three times daily (most cost-effective) 6
  • Alternatives if not tolerated: ferrous gluconate or ferrous fumarate 6
  • Co-administer with vitamin C to enhance absorption 6
  • Avoid tea and coffee around dosing times (impair absorption) 7

Monitoring Response

  • Hemoglobin should rise by 2 g/dL after 3-4 weeks 6
  • Failure to respond indicates:
    • Poor compliance (most common)
    • Continued blood loss
    • Malabsorption
    • Misdiagnosis 6

Parenteral Iron

Reserve for:

  • Intolerance to at least two oral preparations
  • Documented malabsorption (e.g., celiac disease)
  • Not recommended routinely as response is no faster than oral therapy and carries risk of anaphylaxis 6

Key Clinical Caveats

  • Do not delay investigation based on hemoglobin level: Even mild anemia with iron deficiency warrants evaluation, as severity does not predict presence of serious pathology 2, 6
  • Ferritin can be falsely elevated: As an acute phase reactant, ferritin may appear normal in iron deficiency with concurrent inflammation, malignancy, or liver disease 2, 6
  • Reticulocyte count: If available, a low reticulocyte index (<2.0) confirms decreased RBC production consistent with iron deficiency 1
  • Resolution timeline: Aim for anemia resolution within 6 months; persistent anemia requires further investigation 6

Related Questions

What does a hemoglobin of 11.4 g/dL, hematocrit 39.3 %, MCH 29 pg, MCHC 29.0 g/dL, and RDW 18.6 % indicate, and what are the appropriate next diagnostic and treatment steps?
What is the clinical significance of a hemoglobin of 14.2 g/dL, mean corpuscular hemoglobin concentration (MCHC) of 31.5 g/dL, and red cell distribution width (RDW) of 17.8%?
What is the diagnosis and recommended management for a 33-year-old female with hemoglobin 8.9 g/dL, hematocrit 30.8 %, mean corpuscular volume 69.5 fL, mean corpuscular hemoglobin 20.1 pg, mean corpuscular hemoglobin concentration 28.9 g/dL, red cell distribution width 16.5 %, and platelet count 239 ×10⁹/L?
In a 55-year-old man with low mean corpuscular hemoglobin (MCH 26 pg), low mean corpuscular hemoglobin concentration (MCHC 29.8 g/dL), elevated red‑cell distribution width (RDW 16.2 %) and normal red blood cell count, hemoglobin, and hematocrit, what is the likely diagnosis and appropriate next steps?
Interpret the CBC results showing hemoglobin 12.7 g/dL (low), hematocrit 40.4 %, MCV 80 fL, MCH 25.2 pg (low), MCHC 31.4 g/dL (low), and RDW 17.7 % (high).
What is the most appropriate anti‑tuberculosis regimen, including adjunctive therapy, for a 35‑year‑old Indian man with a three‑month history of lethargy, weight loss, headache, and PCR‑confirmed Mycobacterium tuberculosis?
What is the most appropriate treatment regimen for a 35-year-old Indian man presenting with three months of lethargy, weight loss, and headache, a history of tuberculosis exposure, normal neurological and ophthalmologic examinations, and a positive polymerase chain reaction for Mycobacterium tuberculosis?
Can flat feet associated with bunions lead to hammertoes?
After surgical incision and drainage of a hordeolum (stye) in an adult, is antibiotic therapy required?
What is an Ewing tumor (Ewing sarcoma)?
What alternative treatments are available for adenomyosis in a patient who cannot use an intrauterine device?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.